BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022 Mar 03, 2022 6:30am EST
BIOLASE Announces Distribution of Series G Preferred Stock to Holders of Its Common Stock Mar 01, 2022 4:15pm EST
BIOLASE Announces Continuation of Exclusive Collaboration with BMW Performance Center West (BMW PCW) and Winner of BMW Sweepstakes Jan 20, 2022 8:30am EST
BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM Jan 10, 2022 6:30am EST
BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists Jan 06, 2022 9:00am EST
BIOLASE TO PRESENT AT THE H.C. WAINWRIGHT BIOCONNECT VIRTUAL INVESTOR CONFERENCE Jan 05, 2022 8:30am EST
Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement And Enters Into Favorable Credit Agreement Amendment Nov 23, 2021 4:19pm EST
BIOLASE To Present At The Benchmark Company Discovery One-On-One Virtual Investor Conference On December 2, 2021 Nov 23, 2021 6:30am EST
